Stocks and Investing Stocks and Investing
Thu, December 22, 2016
Wed, December 21, 2016

Paul Matteis Initiated (CDTX) at Buy and Held Target at $340 on, Dec 21st, 2016


Published on 2024-10-25 19:45:55 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Initiated "Cidara Therapeutics, Inc." (CDTX) at Buy and Held Target at $340 on, Dec 21st, 2016.

Paul has made no other calls on CDTX in the last 4 months.



There are 2 other peers that have a rating on CDTX. Out of the 2 peers that are also analyzing CDTX, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Ed Arce of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $500 on, Monday, December 19th, 2016
  • Stephen Brozak of "WBB Securities" Downgraded from Hold to Strong Sell on, Friday, September 23rd, 2016

Contributing Sources